Die Yu
Impact in
-
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Shuaishuai Chen (2 shared papers)Juping Du (2 shared papers)Xia Pu (2 shared papers)Na Wang (1 shared paper)Shiyong Chen (2 shared papers)Liyuan Zheng (1 shared paper)Bo Shen (3 shared papers)Jun Li (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (1 paper)Frontiers in Genetics (1 paper)IEEE Open Journal of the Industrial Electronics Society (1 paper)Environmental Research (1 paper)Cancer Science (1 paper)
- Partner nations
- ChinaSaudi ArabiaUnited Arab Emirates
In The Last Decade
Die Yu
18 papers receiving 442 citations
Peers
Comparison fields: 5 of 85
- Biological Psychiatry 10
- Cancer Research 57
- Infectious Diseases 57
- Molecular Biology 205
- Rheumatology 30
Countries citing papers authored by Die Yu
This map shows the geographic impact of Die Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Die Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Die Yu more than expected).
Fields of papers citing papers by Die Yu
This network shows the impact of papers produced by Die Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Die Yu. The network helps show where Die Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Die Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 117 | |
| 2 | 2021 | 112 | |
| 3 | 2018 | 34 | |
| 4 | 2022 | 26 | |
| 5 | 2023 | 24 | |
| 6 | 2022 | 21 | |
| 7 | 2022 | 18 | |
| 8 | 2024 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2017 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2025 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Die Yu
Die Yu is a scholar working on Cancer Research, Sensory Systems, Molecular Biology, Immunology and Neurology, having authored 20 papers that have together received 446 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers), Long-Term Effects of COVID-19 (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers), COVID-19 and Mental Health (2 papers), Tryptophan and brain disorders (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Biological Psychiatry (10 citations), Cancer Research (57 citations), Infectious Diseases (57 citations), Molecular Biology (205 citations) and Rheumatology (30 citations). Die Yu has collaborated with scholars based in China, Saudi Arabia and United Arab Emirates. Frequent co-authors include Shuaishuai Chen, Juping Du, Xia Pu, Na Wang, Shiyong Chen, Liyuan Zheng, Bo Shen, Jun Li, Ke Xu and Yuxin Lu. Their work appears in journals such as Toxicology and Applied Pharmacology, Frontiers in Genetics, IEEE Open Journal of the Industrial Electronics Society, Environmental Research and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.